Biogen, Swedish Orphan Biovitrum sales and marketing update

Swedish Orphan launched Elocta in Denmark and Germany as on-demand and prophylactic treatment of hemophilia A. Swedish Orphan declined to provide a price. The long-acting recombinant fusion protein c...